Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics said on Sunday that it anticipates its fourth quarter revenues to be down 14 percent year over year.

Accelerate's total fourth quarter revenues are expected to retreat to approximately $1.8 million from $2.1 million a year ago. The figure would miss the analysts' average estimate of $2.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies. 

Sponsored by

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.